0001193125-25-178022 Sample Contracts
SUMMIT THERAPEUTICS INC. AMENDMENT NO. 1 TO DISTRIBUTION AGREEMENTDistribution Agreement • August 11th, 2025 • Summit Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 11th, 2025 Company Industry Jurisdiction
DISTRIBUTION AGREEMENTDistribution Agreement • August 11th, 2025 • Summit Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 11th, 2025 Company Industry JurisdictionSummit Therapeutics Inc., a Delaware corporation (the “Company”), confirms its agreement with J.P. Morgan Securities LLC, as agent and/or principal under any Terms Agreement (as defined in Section 1(a) below) (“you” or the “Agent”), with respect to the issuance and sale from time to time by the Company, in the manner and subject to the terms and conditions described below in this Distribution Agreement (this “Agreement”), of Common Stock, $0.01 par value per share (the “Common Stock”), of the Company having an aggregate Gross Sales Price (as defined in Section 2(b) below) of up to $90,000,000 (the “Maximum Amount”) on the terms set forth in Section 1 of this Agreement. Such shares are hereinafter collectively referred to as the “Shares” and are described in the Prospectus referred to below.